Since its approval as the first PD-1/PD-L1 inhibitor, on September 4, 2014, Keytruda has stood on the top of the heap and dominated attention across the spectrum of industry watchers. At present, the competition in this field is especially fierce. All five PD-1/PD-L1 inhibitors on the market are actively expanding their territories and rapidly pushing …
Across the globe, many countries have pegged big hopes on biosimilars. The situation is no different in China. In the face of the supportive pharmaceutical industry policies, the biosimilar drug development in China is riding on an upward trend. However, compared to the advanced US and European market, China still has plenty of room to …
On March 12, 2018 the Chinese FDA (CFDA) approved the clinical trial application of LCAR-B38M CAR-T cell self-reinfusion preparation from Nanjing Legend Biotech, marking the first cellular therapy to officially enter the clinical trial stage in China. LCAR-B38M is targeted at B-cell maturation antigen (BCMA), a member of TNF receptor family and also an extremely …
For the majority of traditional pharma companies, 2017 was a tough year. A round of new policies repeatedly challenged and changed the industry status quo. For innovative pharmas, however, it was different story – a year full of hopes and opportunities. Thanks to the steady increase in healthcare need, the introduction of policies favorable to …
A deep dive of the Chinese pharmaceutical industry in 2017 Once again, it is the time to do a deep dive of the Chinese pharmaceutical industry in 2017. Recently, East Money Information has published their latest Chinese top 500 company list for the past year. Among them, 42 pharmaceutical companies have the honor to join …
An overview of the new progress in the pharmaceutical industry in 2017 In this article, I detailed 3 breakthroughs in the pharmaceutical industry in 2017. Breakthrough of “0”: On 2 June 2017, China formally became a member of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), marking …
The Chinese innovative medicine field is marching into a new phase. The number of novel drugs has exploded in the past few years and is riding on a steady upward trend. It is predicted that 15 to 20 new drugs will be approved from 2018 to 2020, at a speed of 4 to 5 per …
In 2017, gene technology has achieved extensive advancements. In this article, I am going to discuss 8 major events happened this year. 1. The first human genetic modification therapy was officially launched Brian Madeux, suffering from a rare condition called Hunter Syndrome, has all eyes fixed on him in 2017. He is the first patient …
In the recent years, the healthcare industry has been gaining steam across the spectrum of various industries, from internet to real estate, to high tech and traditional manufacturing, etc. A slew of business giants is marching into this field, and this is especially true in 2017. Several famous new faces have joined the rank. Wanda …
Next Generation Sequencing (NGS) has been standing on the top of the heap in the past few years. Riding on this steady upward trend, a slew of biotech companies has achieved great successes, such as Illumina and Beijing Genomics Institute. Nowadays, a new technology called the third-generation gene sequencing is gradually gaining attention and began …